Physician

Milena Jani, M.D.

According to 2025 Medicare claims, Milena Jani, M.D. (NPI: 1447411004) practices advanced heart failure and transplant cardiology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is SPECTRUM HEALTH PRIMARY CARE PARTNERS (NPI: 1235188673; TIN: 381358164) and primary practice location at 49503-2560. Jani is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Jani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 386 traditional Medicare patients, billed 849 HCPCS/CPT codes, and received $57,005 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,616 prescription claims across 430 beneficiaries totaling $3,467,544 in drug costs, led by Vyndamax (Tafamidis). DME data shows 13 claims. Open Payments data shows 10 records totaling $584. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $22,753 and ending at $57,005. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $10,493 to $3,467,544. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $5,845 to $6,865.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	74	430	$22,753
2016	392	1,354	$67,081
2017	930	1,736	$66,402
2018	779	1,368	$56,572
2019	826	1,444	$59,387
2020	743	1,275	$53,036
2021	597	1,060	$49,457
2022	472	768	$35,560
2023	455	807	$41,802
2024	386	849	$57,005

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	19	67	$10,493
2016	74	302	$19,205
2017	143	573	$55,628
2018	183	823	$71,784
2019	217	1,428	$186,213
2020	280	1,942	$461,699
2021	348	2,347	$784,338
2022	418	2,979	$1,166,303
2023	406	2,825	$1,463,731
2024	430	2,616	$3,467,544

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	26	$2,222
2017	N/R	40	$1,211
2018	N/R	86	$5,733
2019	N/R	322	$25,307
2020	N/R	427	$32,292
2021	N/R	190	$15,492
2022	N/R	135	$13,447
2023	N/R	54	$6,275
2024	N/R	13	$1,045

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	75	98	$108
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	43	90	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	32	39	$74
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	120	122	$52
93325	Ultrasound of heart with color-depicted blood flow, rate and valve function	51	55	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	87	2,850	$2,171,966
Vyndaqel	Tafamidis Meglumine	17	510	$405,240
Entresto	Sacubitril/Valsartan	263	14,588	$313,964
Eliquis	Apixaban	196	11,258	$206,535
Jardiance	Empagliflozin	129	8,682	$158,281

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$1,045

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$584	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Milena Jani, M.D.?

Tedicare shows public-source Medicare data for Milena Jani, M.D. (NPI 1447411004), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Milena Jani, M.D. have ACO affiliation data?

Milena Jani, M.D. is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Milena Jani, M.D.?

Milena Jani, M.D. is linked to SPECTRUM HEALTH PRIMARY CARE PARTNERS (billing NPI 1235188673) in the available physician profile data.

Does Milena Jani, M.D. have Open Payments data?

Milena Jani, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.